BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25764925)

  • 1. [Dynamic observation on the short-term change of xerostomia after intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma].
    Li Y; Zhao C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 50(1):33-7. PubMed ID: 25764925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on DWMRI in evaluating the influence of intensity modulated radiotherapy on salivary gland function of nasopharyngeal carcinoma patients].
    Li Y; Zhao C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 50(9):754-9. PubMed ID: 26696349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation.
    Shi D; Qian JJ; Fan GH; Shen JK; Tian Y; Xu L
    BMC Oral Health; 2019 Dec; 19(1):288. PubMed ID: 31864328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up.
    Sim C; Soong YL; Pang E; Lim C; Walker GD; Manton DJ; Reynolds EC; Wee J
    Aust Dent J; 2018 Jun; 63(2):217-223. PubMed ID: 29569726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study.
    Fan WJ; Teng F; Luo YR; Yu W; Zhang Q; Lu YP; Ma L
    Strahlenther Onkol; 2020 Jun; 196(6):530-541. PubMed ID: 32025803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of salivary function change in nasopharyngeal carcinoma treated by parotid-sparing radiotherapy.
    Liu WS; Kuo HC; Lin JC; Su MC; Lee JK; Chou MJ; Chou MC; Lee H
    Cancer J; 2006; 12(6):494-500. PubMed ID: 17207319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Changes in Apparent Diffusion Coefficient for Salivary Glands during Radiotherapy for Nasopharyngeal Carcinoma Associated with Xerostomia.
    Zhang Q; Wei YM; Qi YG; Li BS
    Korean J Radiol; 2018; 19(2):328-333. PubMed ID: 29520191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance sialography for investigating major salivary gland duct system after intensity-modulated radiotherapy of nasopharyngeal carcinoma.
    Ou D; Zhang Y; He X; Gu Y; Hu C; Ying H; Zhu G; Wu Y; Mao J; Yue L; Shen X
    Int J Clin Oncol; 2013 Oct; 18(5):801-7. PubMed ID: 22892798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
    Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
    J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal Evolution of Parotid Volume and Parotid Apparent Diffusion Coefficient in Nasopharyngeal Carcinoma Patients Treated by Intensity-Modulated Radiotherapy Investigated by Magnetic Resonance Imaging: A Pilot Study.
    Juan CJ; Cheng CC; Chiu SC; Jen YM; Liu YJ; Chiu HC; Kao HW; Wang CW; Chung HW; Huang GS; Hsu HH
    PLoS One; 2015; 10(8):e0137073. PubMed ID: 26323091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research Value of Intensity Modulated Radiation Therapy in Alleviating Parotid Gland Function Injury in Patients with Stage N0 Nasopharyngeal Carcinoma from Physical and Dosimetric Aspects.
    Zheng L; Wang H; Yang N; Du F; Xiao L; Wu G
    Comput Math Methods Med; 2022; 2022():4651364. PubMed ID: 35860184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer - A prospective cohort analysis.
    Sommat K; Hussain A; Ong WS; Yit NLF; Khoo JBK; Soong YL; Wee JTS; Fong KW; Tan TWK
    Radiother Oncol; 2019 Sep; 138():149-157. PubMed ID: 31265972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of protective effects on salivary and swallowing structures and improvement of late xerostomia and dysphagia by level IIb optimisation in clinical target volume of nasopharyngeal carcinoma.
    Zhou J; Wang L; Qiu T; Gao H; Wang L; Huang S; He X; Wu L
    BMC Cancer; 2024 May; 24(1):648. PubMed ID: 38802747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The quantitative evaluation of early radiation-induced changes in the salivary glands using MRI].
    Zhou S; Qian JJ; Xu L; Tian Y; Fan QH; Shen JK; Fan GH; Gong JP; Qian MH
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(7):492-495. PubMed ID: 28260286
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective investigation and literature review of tolerance dose on salivary glands using quantitative salivary gland scintigraphy in the intensity-modulated radiotherapy era.
    Lee SW; Kang KW; Wu HG
    Head Neck; 2016 Apr; 38 Suppl 1():E1746-55. PubMed ID: 26875880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.
    Kam MK; Leung SF; Zee B; Chau RM; Suen JJ; Mo F; Lai M; Ho R; Cheung KY; Yu BK; Chiu SK; Choi PH; Teo PM; Kwan WH; Chan AT
    J Clin Oncol; 2007 Nov; 25(31):4873-9. PubMed ID: 17971582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the parotid function in nasopharyngeal carcinoma treated with parotid-sparing radiotherapy.
    Liu WS; Lee SP; Lee JK; Su MC; Chen GD; Lee HS; Lee H
    Jpn J Clin Oncol; 2006 Oct; 36(10):626-31. PubMed ID: 17008345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Salivary Gland Function Using Diffusion-Weighted Magnetic Resonance Imaging for Follow-Up of Radiation-Induced Xerostomia.
    Zhang Y; Ou D; Gu Y; He X; Peng W
    Korean J Radiol; 2018; 19(4):758-766. PubMed ID: 29962882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical observation of submandibular gland transfer for the prevention of xerostomia after radiotherapy for nasopharyngeal carcinoma: a prospective randomized controlled study of 32 cases.
    Zhang X; Liu F; Lan X; Yu L; Wu W; Wu X; Xiao F; Li S
    Radiat Oncol; 2014 Feb; 9():62. PubMed ID: 24555575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.